Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Martek/General Mills

This article was originally published in The Tan Sheet

Executive Summary

Martek Biosciences has entered into a 15-year DHA license and supply agreement with General Mills, the firm announces June 16. Under the terms of the agreement, the food company "may develop certain food products containing Martek DHA and must purchase, subject to certain exceptions, substantially all of its DHA needs from Martek for these products in the United States and other designated territories," the release states. Furthermore, General Mills products containing Martek DHA are required to bear the Martek DHA logo on the product labeling as well as related marketing, advertising and promotional materials. The initial launch of a General Mills/Martek DHA product is slated for 2007, according to Martek. General Mills owns a variety of cereal, snack and processed food brands, including Yoplait, Colombo, Bisquick, Nature Valley and Fruit Roll-Ups...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS099477

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel